tradingkey.logo

Canadian cannabis firm Organigram's Q1 net revenue jumps 49%

ReutersFeb 10, 2026 11:08 AM


Overview

  • Canada cannabis firm's fiscal Q1 net revenue rose 49% yr/yr but missed analyst expectations

  • Adjusted EBITDA for fiscal Q1 increased significantly, driven by higher recreational and international revenue

  • Company achieved genetic screening breakthrough for powdery mildew resistance, improving yield stability


Outlook

  • Organigram expects continued growth in international sales throughout Fiscal 2026

  • Company is preparing for EU-GMP certification for its Moncton facility


Result Drivers

  • MOTIF ACQUISITION - Net revenue growth driven by contributions from Motif Labs acquisition and increased international sales

  • GROSS MARGIN IMPROVEMENT - Adjusted gross margin rose due to operational efficiencies, higher flower yields, and Motif integration synergies

  • GENETIC BREAKTHROUGH - Achieved genetic screening breakthrough for powdery mildew resistance, enhancing yield stability and reducing costs


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Miss

C$63.54 mln

C$73.15 mln (5 Analysts)

Q1 Gross Revenue

C$97.30 mln

Q1 Net Income

C$19.97 mln

Q1 Adjusted EBITDA

C$5.27 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Organigram Global Inc is C$3.25, about 49.8% above its February 9 closing price of C$2.17

Press Release: ID:nBw9TxzBHa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI